» Articles » PMID: 22925351

Subthreshold Symptoms and Time to Relapse/recurrence in a Community Cohort of Bipolar Disorder Outpatients

Overview
Journal J Affect Disord
Date 2012 Aug 29
PMID 22925351
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Researchers have previously found that persistent subthreshold symptoms increase the risk and shorten the time until an affective relapse in bipolar disorder (BD) patients. Research has mainly focused on patients from tertiary Care Centers in USA. We tested the hypothesis that even in a different setting, BD outpatients with subsyndromal affective symptoms would re.turn to a subsequent major affective episode significantly faster than completely asymptomatic at baseline. Secondarily, we analysed other variables related to time and risk to relapse.

Methods: A community cohort of BD outpatients from Madrid (Spain) followed-up in a systematic prospective follow-up protocol for up to five years were evaluated. Patients in clinical euthymia at baseline were included and evaluated quarterly.

Results: Initially, 225 patients were included in the survival analysis. Of them, according to predefined psychometric criteria, 163 were in euthymia (72.4%) and 62 (27.6%) suffered subsyndromal symptoms. Median follow-up was 157.6 weeks (95% CI, 78.14 to 111); 57.3% of patients experienced at least one affective episode during their follow-up. Median survival time to first affective episode was 109 weeks for patients in euthymia at baseline, versus 35 weeks for those with subsyndromal symptoms (p<0.0001). Psychosocial stress (p=0.003; HR 2.20; 95% CI 1.31-3.68) and the affective mood baseline state, subsyndromal vs. euthymic (p=0.046; HR 1.74; 95%CI 1.009-3.020), were related to time to first affective episode.

Limitations: Naturalistic study, some of the data collected were necessarily retrospective.

Conclusions: In Spanish non-tertiary psychiatric outpatients, subsyndromal BD symptoms and psychosocial stress at baseline predict earlier episode relapse/recurrence.

Citing Articles

Executive function performance in high and low medication adherent patients with euthymic bipolar i disorder: a comparative study.

Rahimi Chahooei M, Zahedi Tajrishi K, Zargarinejad G, Shabani A BMC Psychiatry. 2025; 25(1):239.

PMID: 40082820 PMC: 11905722. DOI: 10.1186/s12888-025-06665-y.


Rates and associations of relapse over 5 years of 2649 people with bipolar disorder: a retrospective UK cohort study.

Hett D, Morales-Munoz I, Durdurak B, Carlish M, Marwaha S Int J Bipolar Disord. 2023; 11(1):23.

PMID: 37391627 PMC: 10313572. DOI: 10.1186/s40345-023-00302-x.


KIOS: A smartphone app for self-monitoring for patients with bipolar disorder.

Pahwa M, McElroy S, Priesmeyer R, Siegel G, Siegel P, Nuss S Bipolar Disord. 2023; 26(1):84-92.

PMID: 37340215 PMC: 10730767. DOI: 10.1111/bdi.13362.


A New Treatment Protocol of Combined High-Dose Levothyroxine and Repetitive Transcranial Magnetic Stimulation for the Treatment of Rapid-Cycling Bipolar Spectrum Disorders: A Cohort Evaluation of 55 Patients.

Zamar A, Kouimtsidis C, Lulsegged A, Roberts R, Koutsomitros T, Stahl D J Clin Med. 2022; 11(19).

PMID: 36233698 PMC: 9572106. DOI: 10.3390/jcm11195830.


Strategies and foundations for scientific discovery in longitudinal studies of bipolar disorder.

McInnis M, Andreassen O, Andreazza A, Alon U, Berk M, Brister T Bipolar Disord. 2022; 24(5):499-508.

PMID: 35244317 PMC: 9440950. DOI: 10.1111/bdi.13198.